TrialThe oncologist2019

A Phase II Randomized Trial of Panitumumab, Erlotinib, and Gemcitabine Versus Erlotinib and Gemcitabine in Patients with Untreated, Metastatic Pancreatic Adenocarcinoma: North Central Cancer Treatment Group Trial N064B (Alliance).

Thorvardur R Halfdanarson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.